Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Genomic Lens Linking Worlds in DNA
Adding a new dimension to drug discovery
Breakthrough in Artificial Intelligence
Is ChatGPT the AI revolution we were waiting for or only media hype? Experts from Boehringer Ingelheim take a close look.
Heart disease and treatments can be similar in humans and animals. How?
Humans and animals are more alike than different. Having a heart disease can affect us similarly, and the way to prevent it can work for all as well. Watch and learn how
Discover our global career opportunities
We offer a wide range of career development opportunities in over 140 affiliates worldwide. Click "Read more" to check out the local career sites.
Working at Boehringer Ingelheim
As a research-driven pharmaceutical company Boehringer Ingelheim strives to improve health of people and animals everywhere in the world.
Financial Highlights 2021
Net sales, Research and Development expenditures, Operating Income and Personnel Capacity: Boehringer Ingelheim grows
Annual Report 2021: Tomorrow
Tomorrow holds great opportunities for more progress, more sustainability, and better health. Read inspiring stories on our understanding of a healthier future in our annual report.
Boehringer Ingelheim Corporate Factsheet
Find all important information about our company at a glance.
Company Profile Boehringer Ingelheim
Value through Innovation
Major consolidated companies
Overview of selected consolidated companies
Related Press Releases
January 17, 2023
Global Top Employer 2023
August 03, 2022